HAE R&D to Revenue
Haemonetics Corp · R&D to Revenue
HAE R&D to Revenue
Latest reported4.48%period ending
HAE FY R&D/Revenue (0.00% → 4.48%)
Latest values, visible window
High-resolution chart · PNG
HAE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.4801% | |
| 5.1015% | |
| 4.8153% | |
| 5.0169% | |
| 5.5579% | |
| 4.6707% | |
| 3.9539% | |
| 3.6911% | |
| 4.3398% | |
| 5.3329% | |
| 6.1469% | |
| 5.9522% | |
| 5.7751% | |
| 5.4531% | |
| 5.0562% | |
| 4.8258% | |
| 4.0866% | |
| 3.9906% | |
| 4.7095% | |
| 5.3122% | |
| 6.3173% | |
| 5.2122% | |
| 4.8851% | |
| 5.7907% | |
| 6.0981% | |
| 6.4789% | |
| 5.3709% | |
| 5.3527% | |
| 6.2631% | |
| 6.133% | |
| 6.6499% | |
| 6.3643% | |
| 6.3607% | |
| 0% | |
| 0% | |
| 0% |